LMN-201 for Prevention of C. Difficile Infection Recurrence

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Clostridioides Difficile Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Kaiser Permanente, Escondido, California, United States

    Contact: Study coordinator (Primary Coordinator) · 626-372-7499
  • Bridgeport Hospital, Bridgeport, Connecticut, United States

    Contact: Study coordinator (Primary Coordinator) · 203-384-4700
  • Gastroenterology Center of Connecticut, Hamden, Connecticut, United States

    Contact: Study coordinator (Primary Coordinator) · 203-281-5112
  • GI PROS Research, Naples, Florida, United States

    Contact: Study coordinator (Primary Coordinator) · 239-649-1336
  • Metro Infectious Disease Consultants - Atlanta, Decatur, Georgia, United States

    Contact: Study coordinator (Primary Coordinator) · 404-297-5008
  • Snake River Research, Idaho Falls, Idaho, United States

    Contact: Study coordinator (Primary Coordinator) · 208-535-8406
  • Metro Infectious Disease Consultants, LLC, Burr Ridge, Illinois, United States

    Contact: Study coordinator (Primary Coordinator) · 630-655-8441
  • DM Clinical Research, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Primary Coordinator) · (708) 253-5810
  • Baptist Health Research, Lexington, Kentucky, United States

    Contact: Study coordinator (Primary Coordinator) · 859-639-3720
  • University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Primary Coordinator) · 612-625-2998
  • Mercury Street Medical, Butte, Montana, United States

    Contact: Study coordinator (Primary Coordinator) · 406-723-1387
  • Quality Clinical Research, Inc, Omaha, Nebraska, United States

    Contact: Study coordinator (Primary Coordinator) · (402) 934-0044
  • Weill Cornell Medicine, New York, New York, United States

    Contact: Study coordinator (Primary Coordinator) · 646-962-9358
    Study coordinator · 646-962-2085
  • IMA Clinical Research, Mount Airy, North Carolina, United States

    Contact: Study coordinator (Primary Coordinator) · 336-415-5507
  • MD Anderson Cancer Center, Houston, Texas, United States

    Contact: Study coordinator (Primary Coordinator) · 3467251272
  • Clinical Alliance for Infectious Diseases - Infectious Diseases, LLC, Annandale, Virginia, United States

    Contact: Study coordinator (Primary Coordinator) · 7035604821